Enasidenib-induced differentiation promotes sensitivity to venetoclax in IDH2-mutated acute myeloid leukemia.

Severine CathelinDavid SharonAmit SubediDan CojocariDarren C PhillipsJoel D LeversonKyle J MacBethBrandon NicolayRohini NarayanaswamySebastien RonseauxGuowen LiuSteven M Chan

Published in: Leukemia (2021)

Keyphrases

acute myeloid leukemia
high glucose
diabetic rats
wild type
low grade
drug induced
oxidative stress
chronic lymphocytic leukemia
high grade